ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
Dow Jones
42.706,56
-0,06%
Euro vs US Dollar
1,03896
0,82%
Bitcoin
102.051,02
3,79%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Kane Biotech Inc (KNE) Börsenkurse

Kane Biotech Inc

Kane Biotech Inc (KNE)

TSXV
0,105
-0,005
(-4,55%)
Geschlossen 07 Januar 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,105
Gebot
0,105
Fragen
0,11
Volumen
26.500
0,105 Tagesbereich 0,105
0,07 52-Wochen-Bereich 0,17
Marktkapitalisierung
13,844M
Handelsende
0,11
Handelsbeginn
0,105
Letzte Trade
15000
@
0.105
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
87.218
Ausgegebene Aktien
131.844.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,50
Gewinn pro Aktie (EPS)
-0,04
Erlöse
2,82M
Nettogewinn
-5,27M

Über Kane Biotech Inc

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.kanebiotech.com
Hauptsitz
Winnipeg, Manitoba, Can
Gegründet
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Börse with ticker KNE. The last closing price for Kane Biotech was $0,11. Over the last year, Kane Biotech shares have traded in a share price range of $ 0,07 to $ 0,17.

Kane Biotech currently has 131.844.000 shares in issue. The market capitalisation of Kane Biotech is $14,50 million. Kane Biotech has a price to earnings ratio (PE ratio) of -2.50.

KNE Neueste Nachrichten

Weitere Nachrichten

Kane Biotech Announces $3,000,000 Private Placement Offering

WINNIPEG, Manitoba, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it intends to undertake a non-brokered...

03 Dezember 2024
GlobeNewswire Inc.

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial...

28 November 2024
GlobeNewswire Inc.

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc...

27 November 2024
GlobeNewswire Inc.

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will release its third quarter 2024 financial results after market close on...

21 November 2024
GlobeNewswire Inc.

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of...

14 November 2024
GlobeNewswire Inc.

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...

14 November 2024
GlobeNewswire Inc.

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet...

12 November 2024
GlobeNewswire Inc.

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial...

23 Oktober 2024
GlobeNewswire Inc.

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...

17 Oktober 2024
GlobeNewswire Inc.

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

03 Oktober 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.00550.10.1150.095999750.10852463CS
4-0.005-4.545454545450.110.1150.09872940.1059783CS
12-0.02-160.1250.140.09872180.11394856CS
26-0.045-300.150.170.091013970.13212871CS
520.0223.52941176470.0850.170.071126060.12804283CS
156-0.04-27.58620689660.1450.170.05686740.11522295CS
260-0.035-250.140.260.05686660.13488199CS

KNE - Frequently Asked Questions (FAQ)

What is the current Kane Biotech share price?
The current share price of Kane Biotech is $ 0,105
How many Kane Biotech shares are in issue?
Kane Biotech has 131.844.000 shares in issue
What is the market cap of Kane Biotech?
The market capitalisation of Kane Biotech is CAD 14,5M
What is the 1 year trading range for Kane Biotech share price?
Kane Biotech has traded in the range of $ 0,07 to $ 0,17 during the past year
What is the PE ratio of Kane Biotech?
The price to earnings ratio of Kane Biotech is -2,5
What is the cash to sales ratio of Kane Biotech?
The cash to sales ratio of Kane Biotech is 4,67
What is the reporting currency for Kane Biotech?
Kane Biotech reports financial results in CAD
What is the latest annual turnover for Kane Biotech?
The latest annual turnover of Kane Biotech is CAD 2,82M
What is the latest annual profit for Kane Biotech?
The latest annual profit of Kane Biotech is CAD -5,27M
What is the registered address of Kane Biotech?
The registered address for Kane Biotech is 290-100 INNOVATION DRIVE, WINNIPEG, MANITOBA, R3T 6G2
What is the Kane Biotech website address?
The website address for Kane Biotech is www.kanebiotech.com
Which industry sector does Kane Biotech operate in?
Kane Biotech operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FINV.PFaction Investment Group Corp
$ 0,05
(233,33%)
17k
ADG.HArcus Development Group Inc
$ 0,015
(200,00%)
10k
AZC.PA2ZCryptocap Inc
$ 0,095
(171,43%)
1,01k
CBAChampion Bear Resources Ltd
$ 0,035
(133,33%)
9k
XBOTRealbotix Corp
$ 0,56
(124,00%)
7,15M
MSPMinaean SP Construction Corp
$ 0,005
(-66,67%)
7k
MUST.HMust Capital Inc
$ 0,025
(-58,33%)
215k
CART.HCarcetti Capital Corp
$ 0,13
(-51,85%)
4,5k
NICKNickelex Resource Corporation
$ 0,005
(-50,00%)
300k
IDIdentillect Technologies Corp
$ 0,005
(-50,00%)
425k
GPUSAlset AI Ventures Inc
$ 0,21
(31,25%)
10,69M
MATEBlockmate Ventures Inc
$ 0,375
(-8,54%)
7,24M
XBOTRealbotix Corp
$ 0,56
(124,00%)
7,15M
QNCQuantum Emotion Corp
$ 1,76
(21,38%)
6,09M
AECAnfield Energy Inc
$ 0,095
(5,56%)
3,84M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
KNE
Kane Biotech
BIT
EGN
Egomnia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten